Cabazitaxel 60 mg / 1.5 mL Injection (Jevtana) — Advanced Chemotherapy for Prostate Cancer Cabazitaxel 60 mg / 1.5 mL Injection is a potent chemotherapy medicine used in the treatment of metastatic castration-resistant prostate cancer, particularly after other chemotherapy treatments like docetaxel have stopped working. Administered by a trained oncology team via intravenous infusion, cabazitaxel belongs to the taxane class of cancer drugs that work by disrupting the division and growth of cancer cells. It is typically given every three weeks in combination with prednisone to improve treatment effects. Due to its powerful action and risk of myelosuppression, infection, and allergic infusion reactions, this medicine must be given under strict medical supervision with regular blood tests and supportive care.